先天性心脏病（CHD）患者中，凝血因子II G20210A突变和凝血因子V Leiden突变与血栓事件无显著关联，支持不常规筛查这些基因型的建议。研究显示，CHD人群的这些突变携带率低于一般人群，可能因胎儿期生存劣势导致。单心室CHD患者血栓事件发生率显著高于双心室 ...
Conclusions Novel antibodies aPS/PT IgG are inversely associated with C3 and C4 levels in APS, independently from treatment, Lupus Anticoagulant or triple positivity. aPS/PT IgG are positively ...
Dr. Frank Brodkey shares key insights from andexanet's development, approval, and real-world clinical trajectory.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果